Alerts will be sent to your verified email
Verify EmailKPL
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Kwality Pharmaceuticals Ltd. is a pharmaceutical formation company manufacturing and exporting finished pharmaceutical formulations in various dosage forms since 1983, following new GMP norms.
Kwality Pharma major competitors are Wanbury, Anuh Pharma, Bharat Parenterals, Ind-Swift Lab., Sakar Healthcare, Lincoln Pharma, Fredun Pharma.
Market Cap of Kwality Pharma is ₹932 Crs.
While the median market cap of its peers are ₹843 Crs.
Kwality Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Dec | Mar Jun Sep | ||||||||||||||||
| Investor Presentation | Jun | Mar May | Mar Jun | Mar May | ||||||||||||||
| Conference Call | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|